• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算由特定生物学机制导致的疾病可预防比例:以吸烟所致肺癌中的多环芳烃为例。

Estimating preventable fractions of disease caused by a specified biological mechanism: PAHs in smoking lung cancers as an example.

作者信息

Cox Louis Anthony Tony, Sanders Edward

机构信息

Cox Associates, 503 Franklin St., Denver, CO 80218, USA.

出版信息

Risk Anal. 2006 Aug;26(4):881-92. doi: 10.1111/j.1539-6924.2006.00785.x.

DOI:10.1111/j.1539-6924.2006.00785.x
PMID:16948683
Abstract

Epidemiology textbooks often interpret population attributable fractions based on 2 x 2 tables or logistic regression models of exposure-response associations as preventable fractions, i.e., as fractions of illnesses in a population that would be prevented if exposure were removed. In general, this causal interpretation is not correct, since statistical association need not indicate causation; moreover, it does not identify how much risk would be prevented by removing specific constituents of complex exposures. This article introduces and illustrates an approach to calculating useful bounds on preventable fractions, having valid causal interpretations, from the types of partial but useful molecular epidemiological and biological information often available in practice. The method applies probabilistic risk assessment concepts from systems reliability analysis, together with bounding constraints for the relationship between event probabilities and causation (such as that the probability that exposure X causes response Y cannot exceed the probability that exposure X precedes response Y, or the probability that both X and Y occur) to bound the contribution to causation from specific causal pathways. We illustrate the approach by estimating an upper bound on the contribution to lung cancer risk made by a specific, much-discussed causal pathway that links smoking to a polycyclic aromatic hydrocarbon (PAH) (specifically, benzo(a)pyrene diol epoxide-DNA) adducts at hot spot codons at p53 in lung cells. The result is a surprisingly small preventable fraction (of perhaps 7% or less) for this pathway, suggesting that it will be important to consider other mechanisms and non-PAH constituents of tobacco smoke in designing less risky tobacco-based products.

摘要

流行病学教科书常常将基于2×2表格或暴露-反应关联的逻辑回归模型得出的人群归因分数解释为可预防分数,即如果去除暴露因素,人群中可预防的疾病比例。一般来说,这种因果解释并不正确,因为统计关联并不一定意味着因果关系;此外,它没有明确去除复杂暴露中的特定成分可以预防多少风险。本文介绍并举例说明了一种从实际中常见的部分但有用的分子流行病学和生物学信息类型计算可预防分数有效因果解释的有用界限的方法。该方法应用了系统可靠性分析中的概率风险评估概念,以及事件概率与因果关系之间的边界约束(例如暴露X导致反应Y的概率不能超过暴露X先于反应Y的概率,或者X和Y同时发生的概率)来界定特定因果途径对因果关系的贡献。我们通过估计一条将吸烟与多环芳烃(PAH)(具体为苯并(a)芘二醇环氧化物-DNA)加合物在肺细胞p53热点密码子处联系起来的特定且备受讨论的因果途径对肺癌风险的贡献上限来说明该方法。结果表明,这条途径的可预防分数出奇地小(可能为7%或更低),这表明在设计风险较低的烟草制品时,考虑烟草烟雾的其他机制和非PAH成分将非常重要。

相似文献

1
Estimating preventable fractions of disease caused by a specified biological mechanism: PAHs in smoking lung cancers as an example.估算由特定生物学机制导致的疾病可预防比例:以吸烟所致肺癌中的多环芳烃为例。
Risk Anal. 2006 Aug;26(4):881-92. doi: 10.1111/j.1539-6924.2006.00785.x.
2
Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.甲基化的CpG二核苷酸是苯并[a]芘二醇环氧化物在哺乳动物细胞中诱导的G到T颠换突变的优先靶点:与吸烟相关肺癌中p53突变谱的相似性。
Cancer Res. 2001 Oct 1;61(19):7110-7.
3
Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.p53热点密码子对苯并(a)芘二醇环氧化物(BPDE)的易变性以及非肿瘤性人肺中p53突变的频率。
Cancer Res. 2001 Sep 1;61(17):6350-5.
4
Determinants of anti-benzo[a]pyrene diol epoxide-DNA adduct formation in lymphomonocytes of the general population.普通人群淋巴细胞中抗苯并[a]芘二醇环氧化物-DNA加合物形成的决定因素。
Mutat Res. 2006 Dec 10;611(1-2):54-63. doi: 10.1016/j.mrgentox.2006.06.034. Epub 2006 Sep 15.
5
An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.一种改进的荧光测定法用于吸烟者肺部苯并(a)芘二醇环氧化物-DNA加合物的剂量测定:与总大分子加合物和芳烃羟化酶活性的比较。
Cancer Res. 1992 Nov 15;52(22):6248-53.
6
Differential c-myc expression profiles in normal human bronchial epithelial cells following treatment with benzo[a]pyrene, benzo[a]pyrene-4,5 epoxide, and benzo[a]pyrene-7,8-9,10 diol epoxide.用苯并[a]芘、苯并[a]芘-4,5-环氧化物和苯并[a]芘-7,8-9,10-二醇环氧化物处理后正常人支气管上皮细胞中c-myc的差异表达谱。
Mol Carcinog. 2004 Jun;40(2):79-89. doi: 10.1002/mc.20023.
7
Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.苯并(a)芘二醇环氧化物诱导的DNA损伤敏感性与肺癌风险:一项病例对照分析。
Cancer Res. 2001 Feb 15;61(4):1445-50.
8
Safety and efficacy of weekly oral oltipraz in chronic smokers.
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):892-9. doi: 10.1158/1055-9965.EPI-04-0585.
9
High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.具有CYP1A1 MspI/Msp - GSTM1*0/*0组合基因型个体的肺和血细胞中苯并[a]芘二醇环氧化物DNA加合物水平较高。
Pharmacogenetics. 1998 Apr;8(2):109-18.
10
Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens.在人类吸烟者中检测到的肺部DNA加合物与典型的多环芳烃致癌物无关。
Chem Res Toxicol. 2006 Feb;19(2):295-9. doi: 10.1021/tx0502443.

引用本文的文献

1
Folic acid supplementation increases survival and modulates high risk HPV-induced phenotypes in oral squamous cell carcinoma cells and correlates with p53 mRNA transcriptional down-regulation.叶酸补充剂可提高口腔鳞状细胞癌细胞的存活率并调节高危 HPV 诱导的表型,且与 p53 mRNA 转录下调相关。
Cancer Cell Int. 2012 Mar 23;12:10. doi: 10.1186/1475-2867-12-10.
2
Genetic mutations associated with cigarette smoking in pancreatic cancer.胰腺癌中与吸烟相关的基因突变。
Cancer Res. 2009 Apr 15;69(8):3681-8. doi: 10.1158/0008-5472.CAN-09-0015. Epub 2009 Apr 7.